Literature DB >> 7947091

In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations.

N van der Veen1, H L van Leengoed, W M Star.   

Abstract

The kinetics of fluorescence in tumour (TT) and subcutaneous tissue (ST) and the vascular effects of photodynamic therapy (PDT) were studied using protoporphyrin IX (PpIX), endogenously generated after i.v. administration of 100 and 200 mg kg-1 5-aminolaevulinic acid (ALA). The experimental model was a rat skinfold observation chamber containing a thin layer of ST in which a small syngeneic mammary tumour grows in a sheet-like fashion. Maximum TT and ST fluorescence following 200 mg kg-1 ALA was twice the value after 100 mg kg-1 ALA, but the initial increase with time was the same for the two doses in both TT and ST. The fluorescence increase in ST was slower and the maximum fluorescence was less and appeared later than in TT. Photodynamic therapy was applied using green argon laser light (514.5 nm, 100 J cm-2). Three groups received a single light treatment at different intervals after administration of 100 or 200 mg kg-1 ALA. In these groups no correlation was found between the fluorescence intensities and the vascular damage following PDT. A fourth group was treated twice and before the second light treatment some fluorescence had reappeared after photobleaching due to the first treatment. Only with the double light treatment was lasting TT necrosis achieved, and for the first time with any photosensitiser in this model this was accomplished without complete ST necrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947091      PMCID: PMC2033562          DOI: 10.1038/bjc.1994.412

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Delta-Aminolaevulic acid and porphyria.

Authors:  A JARRETT; C RIMINGTON; D A WILLOUGHBY
Journal:  Lancet       Date:  1956-01-21       Impact factor: 79.321

2.  Cutaneous phototoxic occurrences in patients receiving Photofrin.

Authors:  T J Dougherty; M T Cooper; T S Mang
Journal:  Lasers Surg Med       Date:  1990       Impact factor: 4.025

Review 3.  Photosensitizers: therapy and detection of malignant tumors.

Authors:  T J Dougherty
Journal:  Photochem Photobiol       Date:  1987-06       Impact factor: 3.421

4.  Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo.

Authors:  R H Pottier; Y F Chow; J P LaPlante; T G Truscott; J C Kennedy; L A Beiner
Journal:  Photochem Photobiol       Date:  1986-11       Impact factor: 3.421

5.  Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid.

Authors:  W E Grant; C Hopper; A J MacRobert; P M Speight; S G Bown
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

Review 6.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy.

Authors:  J C Kennedy; R H Pottier
Journal:  J Photochem Photobiol B       Date:  1992-07-30       Impact factor: 6.252

7.  Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor.

Authors:  B W Henderson; V H Fingar
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

8.  In vivo photodynamic effects of phthalocyanines in a skin-fold observation chamber model: role of central metal ion and degree of sulfonation.

Authors:  H L van Leengoed; N van der Veen; A A Versteeg; R Ouellet; J E van Lier; W M Star
Journal:  Photochem Photobiol       Date:  1993-10       Impact factor: 3.421

9.  Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins.

Authors:  Z Malik; H Lugaci
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

10.  Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.

Authors:  C S Loh; A J MacRobert; J Bedwell; J Regula; N Krasner; S G Bown
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

View more
  15 in total

1.  In vivo quantification of photosensitizer fluorescence in the skin-fold observation chamber using dual-wavelength excitation and NIR imaging.

Authors:  Slávka Kaščáková; Sebastiaan de Visscher; Bastiaan Kruijt; Henriëtte S de Bruijn; Angélique van der Ploeg-van den Heuvel; Henricus J C M Sterenborg; Max J H Witjes; Arjen Amelink; Dominic J Robinson
Journal:  Lasers Med Sci       Date:  2011-01-29       Impact factor: 3.161

2.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.

Authors:  B C Wilson; M S Patterson; L Lilge
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

3.  Laser speckle imaging of dynamic changes in flow during photodynamic therapy.

Authors:  B Kruijt; H S de Bruijn; A van der Ploeg-van den Heuvel; H J C M Sterenborg; D J Robinson
Journal:  Lasers Med Sci       Date:  2006-10-13       Impact factor: 3.161

Review 4.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

5.  Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy.

Authors:  Connor Thunshelle; Rui Yin; Qiquan Chen; Michael R Hamblin
Journal:  Curr Dermatol Rep       Date:  2016-07-13

6.  Assessment of the In Vivo Response to Nanobody-Targeted PDT Through Intravital Microscopy.

Authors:  Henriette S de Bruijn; Ann L B Seynhaeve; Timo L M Ten Hagen; Sabrina Oliveira; Dominic J Robinson
Journal:  Methods Mol Biol       Date:  2022

7.  Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).

Authors:  P Mikvy; H Messman; A J MacRobert; M Pauer; V R Sams; C L Davies; J C Stewart; S G Bown
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.

Authors:  A Obwegeser; R Jakober; H Kostron
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

9.  The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.

Authors:  J Leveckis; N J Brown; M W Reed
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

10.  Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.

Authors:  H Messmann; P Mlkvy; G Buonaccorsi; C L Davies; A J MacRobert; S G Bown
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.